BCL2 and neoplasm: It has been demonstrated that these two compounds promoted apoptosis in primary leukemic cells and reduced tumor growth in different mouse models, likely via NF-κB inhibition and, with regard to IBET-151, also partially via BCL-2 inhibition [18,96,181,182].